Viewing StudyNCT03658772



Ignite Creation Date: 2024-05-06 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 12:53 PM
Study NCT ID: NCT03658772
Status: COMPLETED
Last Update Posted: 2023-10-24
First Post: 2018-08-24

Brief Title: Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer
Sponsor: Arrys Therapeutics
Organization: Arrys Therapeutics

Conditions & Keywords Data

Conditions:
Name
Microsatellite Stable Colorectal Cancer
Keywords:
Name View
IK-007 View
Keynote-878 View
ARY-007 View
Immuno-Oncology View
checkpoint inhibitor View
EP4 View